Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia
Authors
Keywords
Acute myeloid leukemia, Daunorubicin, Pharmacokinetics, Genetic factors
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 78, Issue 5, Pages 1051-1058
Publisher
Springer Nature
Online
2016-10-13
DOI
10.1007/s00280-016-3166-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An update of current treatments for adult acute myeloid leukemia
- (2015) H. Dombret et al. BLOOD
- Curcumin is a tight-binding inhibitor of the most efficient human daunorubicin reductase – Carbonyl reductase 1
- (2015) Jan Hintzpeter et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children’s Oncology Group
- (2014) Patrick Thompson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance
- (2014) Oliver Bruhn et al. Expert Opinion on Drug Metabolism & Toxicology
- Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia
- (2012) Mikkel Krogh-Madsen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Carbonyl Reductase 1 Offers a Novel Therapeutic Target to Enhance Leukemia Treatment by Arsenic Trioxide
- (2012) Miran Jang et al. CANCER RESEARCH
- Carbonyl reductase 1 expression influences daunorubicin metabolism in acute myeloid leukemia
- (2012) Savitha Varatharajan et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- MicroRNAs Differentially Regulate Carbonyl Reductase 1 (CBR1) Gene Expression Dependent on the Allele Status of the Common Polymorphic Variant rs9024
- (2012) James L. Kalabus et al. PLoS One
- Cytogenetic analysis of acute myeloid leukemia with t(8;21) from a tertiary care center in India with correlation between clinicopathologic characteristics and molecular analysis
- (2011) Mayur Parihar et al. LEUKEMIA & LYMPHOMA
- Inverse relationship between leukaemic cell burden and plasma concentrations of daunorubicin in patients with acute myeloid leukaemia
- (2010) Alex Bogason et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The t(6;9)(p22;q34) in myeloid neoplasms: a retrospective study of 16 cases
- (2010) Monika Gupta et al. CANCER GENETICS AND CYTOGENETICS
- Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells
- (2010) Eunyoung Tak et al. JOURNAL OF HEPATOLOGY
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- Naturally Occurring Variants of Human CBR3 Alter Anthracycline In Vitro Metabolism
- (2009) O. S. Bains et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol
- (2009) Georg Hempel et al. PEDIATRIC BLOOD & CANCER
- Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients
- (2008) Suman Lal et al. CANCER SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search